{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:44:45Z","timestamp":1776660285706,"version":"3.51.2"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate potential diagnostic approaches and therapeutic strategies for renal inflammatory myofibroblastic tumors (IMT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Renal IMT is a rare mesenchymal neoplasm with intermediate malignant potential arising within the urinary system. Its clinical presentation and imaging characteristics are nonspecific; thus, histopathological examination remains the diagnostic gold standard. This article presents a retrospective analysis of the clinical course of a single patient diagnosed with renal IMT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient<\/jats:title>\n                    <jats:p>An elderly female presented with intermittent abdominal pain. Abdominal contrast-enhanced computed tomography (CT) revealed a solid mass located in the anterior lip of the right kidney. Following radical right nephrectomy, histopathological evaluation confirmed the diagnosis of renal IMT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At the 3- and 6-month follow-up visits postoperatively, the patient showed no evidence of local recurrence or distant metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Definitive diagnosis of renal IMT relies exclusively on histopathological assessments. For localized disease, complete surgical resection, preferably radical nephrectomy, is the treatment of choice. In advanced or unresectable cases, tyrosine kinase inhibitors and other targeted agents may be considered as potential therapeutic options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1819060","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:13:45Z","timestamp":1776658425000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal inflammatory myofibroblastic tumor: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhentao","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Shandong Second Medical University","place":["Weifang, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urinary Surgery, Weifang People\u2019s Hospital","place":["Weifang, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feihu","family":"Tang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Shandong Second Medical University","place":["Weifang, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Shandong Second Medical University","place":["Weifang, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Urinary Surgery, Weifang People\u2019s Hospital","place":["Weifang, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunye","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Urinary Surgery, Weifang People\u2019s Hospital","place":["Weifang, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2021.100768","article-title":"Inflammatory myofibroblastic tumor: Molecular landscape, targeted therapeutics, and remaining challenges","volume":"45","author":"Mahajan","year":"2021","journal-title":"Curr Problems Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.32604\/or.2024.050350","article-title":"Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment","volume":"32","author":"Chmiel","year":"2024","journal-title":"Or"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2023.10.024","article-title":"Renal inflammatory myofibroblastic tumor","volume":"47","author":"Cui","year":"2024","journal-title":"Asian J Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081327","article-title":"Inflammatory myofibroblastic tumor: An updated review","volume":"17","author":"Choi","year":"2025","journal-title":"Cancers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2023.11.164","article-title":"Inflammatory myofibroblastic tumor with preinvasive carcinoma in the kidney and ureter: A case report","volume":"47","author":"Liu","year":"2024","journal-title":"Asian J Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0274-CC","article-title":"Inflammatory myofibroblastic tumor of the bladder","volume":"138","author":"Alderman","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2013.00023","article-title":"Inflammatory myofibroblastic tumor of the liver: A diagnostic challenge","volume":"2","author":"Elpek","year":"2014","journal-title":"JCTH"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/0284185113500165","article-title":"Computed tomography and magnetic resonance imaging findings of inflammatory myofibroblastic tumors of the head and neck","volume":"55","author":"Gao","year":"2014","journal-title":"Acta Radiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.70027","article-title":"Chinese expert consensus on the diagnosis and treatment of inflammatory myofibroblastic tumor","volume":"16","author":"Si","year":"2025","journal-title":"Thorac Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK -rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Butrynski","year":"2010","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2020.09.026","article-title":"Inflammatory myofibroblastic tumor of the bladder with FN1-ALK gene fusion: Different response to ALK inhibition","volume":"146","author":"Reinhart","year":"2020","journal-title":"Urology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-023-01144-6","article-title":"Update of diagnosis and targeted therapy for ALK+ inflammation myofibroblastic tumor","volume":"24","author":"Wang","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.12.021","article-title":"Inflammatory myofibroblastic tumor: The experience of the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)","volume":"127","author":"Casanova","year":"2020","journal-title":"Eur J Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12032-018-1161-0","article-title":"Clinical and histopathologic correlates and management strategies for inflammatory myofibroblastic tumor of the lung. A case series and review of the literature","volume":"35","author":"Sagar","year":"2018","journal-title":"Med Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1200\/JCO.2013.48.8304","article-title":"Uterine inflammatory myofibroblastic tumor in a 10-year-old girl presenting as polypoid mass","volume":"33","author":"Fraggetta","year":"2015","journal-title":"JCO"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1819060\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:13:46Z","timestamp":1776658426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1819060\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":15,"alternative-id":["10.3389\/fonc.2026.1819060"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1819060","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1819060"}}